Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies.

MLA

Fisher, Brian T., et al. “Approach for Defining Human Adenovirus Infection and Disease for Central Review Adjudication in Clinical Studies.” Pediatric Transplantation, vol. 28, no. 3, May 2024, p. e14750. EBSCOhost, https://doi.org/10.1111/petr.14750.

APA

Fisher, B. T., Blumenstock, J., Boge, C. L. K., Shuster, S., Seif, A. E., Green, M., Michaels, M. G., Alexander, J. L., Ardura, M. I., Miller, T. P., Hijano, D. R., Muller, W. J., Schuster, J. E., Green, A. M., Dulek, D. E., Kajon, A. E., & Danziger-Isakov, L. (2024). Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies. Pediatric Transplantation, 28(3), e14750. https://doi.org/10.1111/petr.14750

Chicago

Fisher, Brian T, Jesse Blumenstock, Craig L K Boge, Sydney Shuster, Alix E Seif, Michael Green, Marian G Michaels, et al. 2024. “Approach for Defining Human Adenovirus Infection and Disease for Central Review Adjudication in Clinical Studies.” Pediatric Transplantation 28 (3): e14750. doi:10.1111/petr.14750.